BARCLAYS PLC UK Regulatory Announcement: Form 8.3 – WILLIS TOWERS WATSON PLC
LONDON–(BUSINESS WIRE)–
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. |
Company dealt in | WILLIS TOWERS WATSON PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) | ORD |
Date of dealing | 12 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,808,712 | 1.40% | 181,790 | 0.14% | ||
(2) | Derivatives (other than options): | ||||
103,127 | 0.08% | 7,066 | 0.01% | ||
(3) | Options and agreements to | ||||
purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
TOTAL: | |||||
1,917,939 | 1.49% | 194,956 | 0.15% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 223.1800 USD |
Purchase | 1 | 223.1200 USD |
Purchase | 2 | 222.6400 USD |
Purchase | 7 | 222.8800 USD |
Purchase | 27 | 222.8383 USD |
Purchase | 46 | 223.3600 USD |
Purchase | 74 | 222.7447 USD |
Purchase | 100 | 222.4300 USD |
Purchase | 107 | 222.0900 USD |
Purchase | 119 | 222.4391 USD |
Purchase | 123 | 222.2813 USD |
Purchase | 124 | 222.5993 USD |
Purchase | 160 | 222.5205 USD |
Purchase | 196 | 222.6369 USD |
Purchase | 200 | 222.7500 USD |
Purchase | 212 | 222.5900 USD |
Purchase | 253 | 222.7973 USD |
Purchase | 259 | 222.2709 USD |
Purchase | 300 | 222.4166 USD |
Purchase | 392 | 222.6063 USD |
Purchase | 1,100 | 222.7615 USD |
Purchase | 1,411 | 222.9362 USD |
Purchase | 2,609 | 222.7936 USD |
Purchase | 4,056 | 222.7624 USD |
Purchase | 20,870 | 222.6615 USD |
Purchase | 24,809 | 222.7600 USD |
Sale | 1 | 222.9700 USD |
Sale | 1 | 222.8500 USD |
Sale | 1 | 222.6200 USD |
Sale | 7 | 222.8907 USD |
Sale | 9 | 222.9056 USD |
Sale | 200 | 222.7500 USD |
Sale | 200 | 222.9050 USD |
Sale | 200 | 223.3600 USD |
Sale | 202 | 222.3655 USD |
Sale | 400 | 222.7218 USD |
Sale | 490 | 222.5724 USD |
Sale | 700 | 222.7842 USD |
Sale | 3,373 | 222.7818 USD |
Sale | 3,861 | 222.7601 USD |
Sale | 5,902 | 222.7526 USD |
Sale | 8,056 | 222.7600 USD |
Sale | 13,555 | 222.7620 USD |
Sale | 21,096 | 222.6501 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure | 15 March 2021 |
Contact name | Large Holdings Regulatory Operations |
Telephone number | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection (Note 10) |
|
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
to which the option | |||||
or derivative | |||||
relates | |||||
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
Contacts
BARCLAYS PLC